{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.08, "width": 1700, "height": 2236, "unit": "pixel", "lines": [{"boundingBox": [91, 26, 268, 25, 269, 46, 92, 47], "text": "08/07/2002", "words": [{"boundingBox": [100, 26, 259, 26, 260, 47, 101, 47], "text": "08/07/2002", "confidence": "Low"}]}, {"boundingBox": [285, 28, 394, 23, 395, 44, 286, 50], "text": "18:47", "words": [{"boundingBox": [308, 28, 386, 24, 388, 45, 310, 49], "text": "18:47"}]}, {"boundingBox": [454, 22, 654, 24, 653, 48, 453, 46], "text": "06 6204 2244", "words": [{"boundingBox": [463, 25, 493, 24, 495, 47, 465, 47], "text": "06"}, {"boundingBox": [509, 24, 574, 24, 577, 47, 511, 47], "text": "6204"}, {"boundingBox": [589, 25, 651, 26, 654, 49, 591, 47], "text": "2244"}]}, {"boundingBox": [53, 47, 600, 45, 601, 69, 54, 71], "text": ". 2002' 08/08 21:50 FAX 06 6204 2244", "words": [{"boundingBox": [54, 49, 67, 49, 67, 71, 54, 71], "text": "."}, {"boundingBox": [71, 48, 144, 48, 144, 71, 71, 71], "text": "2002'", "confidence": "Low"}, {"boundingBox": [149, 48, 227, 48, 227, 71, 148, 71], "text": "08/08"}, {"boundingBox": [245, 47, 323, 47, 323, 71, 245, 71], "text": "21:50"}, {"boundingBox": [339, 47, 386, 47, 386, 70, 339, 70], "text": "FAX"}, {"boundingBox": [402, 47, 432, 47, 433, 70, 402, 70], "text": "06"}, {"boundingBox": [450, 47, 511, 47, 512, 69, 450, 70], "text": "6204"}, {"boundingBox": [528, 46, 590, 46, 590, 69, 529, 69], "text": "2244"}]}, {"boundingBox": [725, 45, 1093, 44, 1094, 69, 726, 70], "text": "TAKEDA DEVELOP DIVISION", "words": [{"boundingBox": [729, 46, 822, 47, 823, 70, 731, 69], "text": "TAKEDA"}, {"boundingBox": [838, 47, 947, 47, 948, 70, 839, 70], "text": "DEVELOP"}, {"boundingBox": [963, 47, 1086, 45, 1087, 70, 963, 70], "text": "DIVISION"}]}, {"boundingBox": [1433, 44, 1574, 45, 1573, 69, 1432, 68], "text": "2 006/006", "words": [{"boundingBox": [1436, 45, 1452, 45, 1452, 69, 1437, 69], "text": "2", "confidence": "Low"}, {"boundingBox": [1463, 45, 1572, 45, 1572, 69, 1463, 69], "text": "006/006"}]}, {"boundingBox": [1411, 186, 1477, 183, 1475, 236, 1409, 238], "text": "6 / 6", "words": [{"boundingBox": [1406, 185, 1421, 184, 1423, 237, 1408, 238], "text": "6"}, {"boundingBox": [1431, 184, 1449, 183, 1451, 236, 1433, 237], "text": "/"}, {"boundingBox": [1459, 183, 1474, 182, 1476, 235, 1461, 236], "text": "6"}]}, {"boundingBox": [297, 343, 1361, 342, 1361, 383, 298, 385], "text": "Discussion points to address the three key issues raised by the FDA", "words": [{"boundingBox": [300, 349, 465, 349, 466, 382, 300, 379], "text": "Discussion"}, {"boundingBox": [477, 349, 576, 349, 576, 383, 478, 382], "text": "points"}, {"boundingBox": [582, 349, 615, 348, 615, 383, 582, 383], "text": "to"}, {"boundingBox": [623, 348, 747, 348, 747, 384, 623, 383], "text": "address"}, {"boundingBox": [753, 348, 806, 348, 806, 385, 753, 384], "text": "the"}, {"boundingBox": [812, 348, 899, 347, 899, 385, 812, 385], "text": "three"}, {"boundingBox": [905, 347, 962, 346, 962, 385, 905, 385], "text": "key"}, {"boundingBox": [968, 346, 1063, 346, 1062, 385, 968, 385], "text": "issues"}, {"boundingBox": [1069, 346, 1167, 345, 1166, 384, 1068, 385], "text": "raised"}, {"boundingBox": [1173, 345, 1217, 344, 1215, 384, 1172, 384], "text": "by"}, {"boundingBox": [1225, 344, 1276, 343, 1275, 383, 1223, 384], "text": "the"}, {"boundingBox": [1284, 343, 1355, 342, 1353, 382, 1282, 383], "text": "FDA"}]}, {"boundingBox": [255, 414, 888, 416, 887, 448, 254, 447], "text": "Date: Monday, 12 and Tuesday, 13 August 2002", "words": [{"boundingBox": [257, 416, 327, 416, 327, 446, 257, 446], "text": "Date:"}, {"boundingBox": [332, 416, 451, 416, 451, 447, 333, 446], "text": "Monday,"}, {"boundingBox": [457, 416, 490, 416, 490, 448, 457, 448], "text": "12"}, {"boundingBox": [496, 416, 546, 416, 547, 448, 496, 448], "text": "and"}, {"boundingBox": [552, 416, 668, 416, 669, 448, 553, 448], "text": "Tuesday,"}, {"boundingBox": [674, 416, 707, 416, 708, 448, 675, 448], "text": "13"}, {"boundingBox": [713, 416, 806, 416, 808, 448, 714, 448], "text": "August"}, {"boundingBox": [812, 416, 880, 416, 882, 447, 814, 448], "text": "2002"}]}, {"boundingBox": [252, 444, 562, 447, 561, 482, 251, 479], "text": "Venue: TPNA, Chicago", "words": [{"boundingBox": [259, 448, 354, 446, 353, 477, 259, 479], "text": "Venue:"}, {"boundingBox": [360, 446, 451, 447, 449, 478, 359, 477], "text": "TPNA,"}, {"boundingBox": [457, 447, 562, 450, 560, 483, 455, 478], "text": "Chicago"}]}, {"boundingBox": [251, 510, 366, 512, 365, 537, 250, 536], "text": "ISSUES", "words": [{"boundingBox": [254, 511, 365, 512, 365, 536, 254, 536], "text": "ISSUES"}]}, {"boundingBox": [259, 542, 1315, 540, 1316, 570, 260, 572], "text": "1. They requested us to propose a method by which to monitor bladder toxicity in", "words": [{"boundingBox": [260, 544, 291, 544, 291, 571, 260, 571], "text": "1.", "confidence": "Low"}, {"boundingBox": [309, 544, 372, 544, 372, 572, 309, 571], "text": "They"}, {"boundingBox": [378, 544, 503, 544, 503, 572, 378, 572], "text": "requested"}, {"boundingBox": [508, 544, 539, 544, 539, 572, 508, 572], "text": "us"}, {"boundingBox": [544, 544, 570, 544, 570, 572, 545, 572], "text": "to"}, {"boundingBox": [575, 544, 680, 544, 681, 572, 576, 572], "text": "propose"}, {"boundingBox": [686, 544, 700, 544, 701, 572, 686, 572], "text": "a"}, {"boundingBox": [706, 544, 805, 544, 806, 572, 706, 572], "text": "method"}, {"boundingBox": [811, 544, 845, 544, 846, 572, 811, 572], "text": "by"}, {"boundingBox": [852, 544, 930, 544, 931, 572, 853, 572], "text": "which"}, {"boundingBox": [936, 544, 963, 544, 964, 572, 937, 572], "text": "to"}, {"boundingBox": [968, 544, 1070, 543, 1071, 571, 969, 572], "text": "monitor"}, {"boundingBox": [1075, 543, 1173, 543, 1174, 571, 1076, 571], "text": "bladder"}, {"boundingBox": [1178, 543, 1280, 542, 1281, 571, 1180, 571], "text": "toxicity"}, {"boundingBox": [1285, 542, 1311, 541, 1312, 571, 1287, 571], "text": "in"}]}, {"boundingBox": [302, 575, 1356, 572, 1357, 604, 303, 606], "text": "patients in our long term phase 4 clinical trials (long term was defined as at least 1", "words": [{"boundingBox": [305, 578, 406, 577, 406, 604, 305, 604], "text": "patients"}, {"boundingBox": [411, 577, 438, 577, 438, 605, 411, 604], "text": "in"}, {"boundingBox": [445, 577, 489, 576, 488, 605, 445, 605], "text": "our"}, {"boundingBox": [494, 576, 555, 576, 554, 605, 493, 605], "text": "long"}, {"boundingBox": [560, 576, 610, 576, 610, 605, 559, 605], "text": "term"}, {"boundingBox": [625, 575, 700, 575, 699, 606, 625, 605], "text": "phase"}, {"boundingBox": [705, 575, 722, 575, 721, 606, 704, 606], "text": "4"}, {"boundingBox": [730, 575, 826, 575, 826, 606, 730, 606], "text": "clinical"}, {"boundingBox": [831, 575, 897, 574, 897, 606, 831, 606], "text": "trials"}, {"boundingBox": [902, 574, 971, 574, 971, 605, 902, 606], "text": "(long"}, {"boundingBox": [976, 574, 1027, 574, 1027, 605, 976, 605], "text": "term"}, {"boundingBox": [1044, 574, 1098, 574, 1097, 605, 1043, 605], "text": "was"}, {"boundingBox": [1104, 574, 1199, 574, 1199, 604, 1104, 605], "text": "defined"}, {"boundingBox": [1204, 574, 1234, 574, 1234, 604, 1204, 604], "text": "as"}, {"boundingBox": [1239, 574, 1263, 574, 1263, 604, 1239, 604], "text": "at"}, {"boundingBox": [1268, 574, 1332, 574, 1332, 603, 1268, 604], "text": "least"}, {"boundingBox": [1337, 574, 1355, 574, 1356, 603, 1337, 603], "text": "1"}]}, {"boundingBox": [302, 609, 371, 610, 371, 638, 303, 637], "text": "year)", "words": [{"boundingBox": [305, 609, 369, 609, 368, 637, 305, 637], "text": "year)"}]}, {"boundingBox": [253, 673, 289, 672, 290, 696, 254, 698], "text": "2.", "words": [{"boundingBox": [257, 672, 287, 671, 288, 696, 258, 697], "text": "2."}]}, {"boundingBox": [291, 666, 1369, 669, 1369, 702, 290, 699], "text": "They indicated an inclination to rescind the written request for pediatric exclusivity", "words": [{"boundingBox": [307, 668, 371, 669, 372, 699, 308, 699], "text": "They"}, {"boundingBox": [377, 669, 498, 669, 499, 699, 378, 699], "text": "indicated"}, {"boundingBox": [504, 669, 534, 670, 535, 699, 505, 699], "text": "an"}, {"boundingBox": [540, 670, 677, 670, 677, 700, 541, 699], "text": "inclination"}, {"boundingBox": [683, 670, 711, 670, 712, 700, 683, 700], "text": "to"}, {"boundingBox": [717, 670, 811, 671, 812, 700, 718, 700], "text": "rescind"}, {"boundingBox": [817, 671, 858, 671, 858, 700, 818, 700], "text": "the"}, {"boundingBox": [864, 671, 956, 671, 957, 701, 864, 701], "text": "written"}, {"boundingBox": [962, 671, 1055, 670, 1055, 701, 963, 701], "text": "request"}, {"boundingBox": [1061, 670, 1097, 670, 1097, 701, 1061, 701], "text": "for"}, {"boundingBox": [1103, 670, 1219, 670, 1220, 702, 1103, 701], "text": "pediatric"}, {"boundingBox": [1225, 670, 1368, 669, 1369, 702, 1226, 702], "text": "exclusivity"}]}, {"boundingBox": [304, 702, 875, 706, 874, 734, 303, 729], "text": "based on their concern about bladder tumors.", "words": [{"boundingBox": [305, 704, 379, 704, 379, 730, 306, 730], "text": "based"}, {"boundingBox": [384, 704, 417, 704, 418, 731, 385, 730], "text": "on"}, {"boundingBox": [426, 704, 487, 704, 488, 731, 427, 731], "text": "their"}, {"boundingBox": [492, 704, 594, 705, 595, 732, 493, 731], "text": "concern"}, {"boundingBox": [601, 705, 673, 705, 674, 732, 602, 732], "text": "about"}, {"boundingBox": [678, 705, 778, 706, 779, 734, 679, 733], "text": "bladder"}, {"boundingBox": [783, 706, 874, 707, 875, 735, 784, 734], "text": "tumors."}]}, {"boundingBox": [256, 768, 1341, 769, 1340, 798, 255, 796], "text": "3. They requested us to give some consideration to a label change that would reflect", "words": [{"boundingBox": [256, 768, 291, 768, 293, 797, 258, 797], "text": "3."}, {"boundingBox": [307, 768, 370, 768, 372, 798, 309, 797], "text": "They"}, {"boundingBox": [376, 768, 500, 769, 502, 798, 378, 798], "text": "requested"}, {"boundingBox": [506, 769, 537, 769, 539, 798, 508, 798], "text": "us"}, {"boundingBox": [543, 769, 571, 770, 572, 798, 545, 798], "text": "to"}, {"boundingBox": [576, 770, 633, 770, 635, 798, 578, 798], "text": "give"}, {"boundingBox": [639, 770, 708, 770, 710, 798, 641, 798], "text": "some"}, {"boundingBox": [714, 770, 887, 771, 889, 798, 716, 798], "text": "consideration"}, {"boundingBox": [893, 771, 920, 771, 922, 798, 895, 798], "text": "to"}, {"boundingBox": [926, 771, 940, 771, 942, 798, 928, 798], "text": "a"}, {"boundingBox": [946, 771, 1011, 771, 1012, 798, 948, 798], "text": "label"}, {"boundingBox": [1017, 771, 1109, 770, 1111, 798, 1018, 798], "text": "change"}, {"boundingBox": [1115, 770, 1164, 770, 1166, 798, 1117, 798], "text": "that"}, {"boundingBox": [1170, 770, 1251, 770, 1252, 798, 1172, 798], "text": "would"}, {"boundingBox": [1257, 770, 1339, 770, 1341, 797, 1258, 798], "text": "reflect"}]}, {"boundingBox": [302, 800, 1404, 798, 1405, 830, 303, 833], "text": "possible relatedness of tumor formation to mechanism (dual PPAR agonist) instead of", "words": [{"boundingBox": [305, 802, 411, 802, 412, 831, 305, 831], "text": "possible"}, {"boundingBox": [417, 802, 560, 802, 561, 832, 417, 831], "text": "relatedness"}, {"boundingBox": [566, 802, 593, 802, 593, 832, 566, 832], "text": "of"}, {"boundingBox": [599, 802, 678, 801, 679, 832, 599, 832], "text": "tumor"}, {"boundingBox": [684, 801, 812, 801, 812, 832, 684, 832], "text": "formation"}, {"boundingBox": [818, 801, 845, 801, 845, 832, 818, 832], "text": "to"}, {"boundingBox": [851, 801, 990, 801, 990, 832, 851, 832], "text": "mechanism"}, {"boundingBox": [1002, 800, 1069, 800, 1069, 832, 1002, 832], "text": "(dual"}, {"boundingBox": [1075, 800, 1153, 800, 1152, 832, 1075, 832], "text": "PPAR"}, {"boundingBox": [1162, 800, 1267, 799, 1266, 832, 1162, 832], "text": "agonist)"}, {"boundingBox": [1273, 799, 1364, 799, 1363, 832, 1272, 832], "text": "instead"}, {"boundingBox": [1369, 799, 1404, 798, 1404, 832, 1369, 832], "text": "of"}]}, {"boundingBox": [304, 832, 1353, 831, 1354, 862, 305, 863], "text": "the current language (\"The relationship of these findings in male rats to humans is", "words": [{"boundingBox": [305, 833, 347, 833, 347, 862, 305, 862], "text": "the"}, {"boundingBox": [353, 833, 445, 833, 444, 863, 352, 862], "text": "current"}, {"boundingBox": [450, 833, 567, 833, 567, 863, 450, 863], "text": "language"}, {"boundingBox": [573, 833, 649, 833, 649, 864, 572, 863], "text": "(\"The"}, {"boundingBox": [655, 833, 808, 832, 808, 864, 655, 864], "text": "relationship"}, {"boundingBox": [814, 832, 841, 832, 840, 864, 813, 864], "text": "of"}, {"boundingBox": [846, 832, 915, 832, 915, 863, 846, 864], "text": "these"}, {"boundingBox": [921, 832, 1026, 832, 1026, 863, 920, 863], "text": "findings"}, {"boundingBox": [1032, 832, 1059, 832, 1058, 863, 1031, 863], "text": "in"}, {"boundingBox": [1065, 832, 1128, 832, 1127, 863, 1064, 863], "text": "male"}, {"boundingBox": [1134, 832, 1181, 832, 1180, 862, 1133, 863], "text": "rats"}, {"boundingBox": [1187, 832, 1214, 832, 1213, 862, 1186, 862], "text": "to"}, {"boundingBox": [1220, 832, 1321, 832, 1320, 861, 1219, 862], "text": "humans"}, {"boundingBox": [1327, 832, 1354, 832, 1353, 861, 1326, 861], "text": "is"}]}, {"boundingBox": [300, 863, 436, 868, 435, 899, 299, 894], "text": "unclear.\")", "words": [{"boundingBox": [305, 867, 434, 868, 434, 900, 306, 893], "text": "unclear.\")"}]}, {"boundingBox": [252, 928, 580, 930, 579, 960, 251, 958], "text": "DISCUSSION POINTS", "words": [{"boundingBox": [256, 930, 447, 932, 448, 960, 257, 958], "text": "DISCUSSION"}, {"boundingBox": [460, 932, 579, 930, 580, 960, 461, 960], "text": "POINTS"}]}, {"boundingBox": [271, 961, 1401, 963, 1400, 996, 270, 995], "text": "to briefly review the toxicity study results of pioglitazone, particularly carcinogenicity", "words": [{"boundingBox": [303, 966, 331, 966, 330, 992, 302, 992], "text": "to"}, {"boundingBox": [336, 966, 424, 965, 423, 993, 335, 992], "text": "briefly"}, {"boundingBox": [429, 965, 512, 965, 511, 994, 428, 993], "text": "review"}, {"boundingBox": [524, 965, 565, 965, 564, 994, 523, 994], "text": "the"}, {"boundingBox": [570, 965, 670, 965, 669, 995, 569, 994], "text": "toxicity"}, {"boundingBox": [675, 965, 746, 965, 745, 995, 674, 995], "text": "study"}, {"boundingBox": [751, 965, 838, 964, 838, 996, 750, 995], "text": "results"}, {"boundingBox": [844, 964, 873, 964, 872, 996, 843, 996], "text": "of"}, {"boundingBox": [878, 964, 1045, 964, 1045, 996, 877, 996], "text": "pioglitazone,"}, {"boundingBox": [1050, 964, 1198, 964, 1198, 996, 1050, 996], "text": "particularly"}, {"boundingBox": [1205, 964, 1401, 963, 1401, 996, 1205, 996], "text": "carcinogenicity"}]}, {"boundingBox": [297, 997, 401, 996, 402, 1019, 298, 1020], "text": "studies", "words": [{"boundingBox": [304, 997, 397, 997, 397, 1020, 304, 1021], "text": "studies"}]}, {"boundingBox": [259, 1029, 288, 1032, 288, 1056, 259, 1053], "text": "b.", "words": [{"boundingBox": [258, 1028, 289, 1031, 286, 1055, 256, 1052], "text": "b."}]}, {"boundingBox": [295, 1026, 829, 1027, 829, 1059, 294, 1058], "text": "to summarise discussions with the CPMP", "words": [{"boundingBox": [304, 1030, 330, 1030, 330, 1056, 304, 1056], "text": "to"}, {"boundingBox": [337, 1030, 478, 1030, 478, 1058, 337, 1057], "text": "summarise"}, {"boundingBox": [487, 1030, 630, 1030, 630, 1059, 487, 1058], "text": "discussions"}, {"boundingBox": [635, 1030, 692, 1029, 693, 1059, 636, 1059], "text": "with"}, {"boundingBox": [699, 1029, 742, 1029, 743, 1059, 700, 1059], "text": "the"}, {"boundingBox": [747, 1029, 828, 1027, 829, 1059, 748, 1059], "text": "CPMP"}]}, {"boundingBox": [275, 1057, 1258, 1060, 1257, 1093, 274, 1091], "text": "to submit literature suggesting that pioglitazone suppresses the cell growth,", "words": [{"boundingBox": [304, 1061, 331, 1061, 330, 1089, 302, 1089], "text": "to"}, {"boundingBox": [337, 1062, 425, 1062, 424, 1090, 335, 1089], "text": "submit"}, {"boundingBox": [431, 1062, 548, 1062, 547, 1091, 429, 1090], "text": "literature"}, {"boundingBox": [553, 1062, 690, 1062, 689, 1092, 552, 1091], "text": "suggesting"}, {"boundingBox": [696, 1062, 746, 1062, 746, 1092, 695, 1092], "text": "that"}, {"boundingBox": [752, 1062, 912, 1062, 912, 1093, 751, 1092], "text": "pioglitazone"}, {"boundingBox": [918, 1062, 1055, 1061, 1055, 1093, 917, 1093], "text": "suppresses"}, {"boundingBox": [1060, 1061, 1102, 1061, 1102, 1093, 1060, 1093], "text": "the"}, {"boundingBox": [1107, 1061, 1158, 1061, 1158, 1093, 1107, 1093], "text": "cell"}, {"boundingBox": [1163, 1060, 1257, 1060, 1257, 1093, 1163, 1093], "text": "growth,"}]}, {"boundingBox": [299, 1093, 716, 1094, 715, 1123, 298, 1122], "text": "particularly urinary bladder cell", "words": [{"boundingBox": [302, 1094, 452, 1094, 453, 1123, 302, 1121], "text": "particularly"}, {"boundingBox": [457, 1094, 552, 1094, 553, 1123, 458, 1123], "text": "urinary"}, {"boundingBox": [558, 1094, 656, 1095, 658, 1122, 559, 1123], "text": "bladder"}, {"boundingBox": [662, 1095, 715, 1096, 716, 1122, 663, 1122], "text": "cell"}]}, {"boundingBox": [262, 1128, 280, 1129, 280, 1149, 261, 1148], "text": "1.", "words": [{"boundingBox": [263, 1128, 280, 1128, 279, 1148, 262, 1147], "text": "1.", "confidence": "Low"}]}, {"boundingBox": [295, 1124, 1339, 1124, 1340, 1157, 296, 1158], "text": "to perform an in-vitro study to evaluate the cell growth and cell growth inhibition", "words": [{"boundingBox": [303, 1127, 330, 1127, 330, 1155, 303, 1154], "text": "to"}, {"boundingBox": [336, 1127, 432, 1127, 432, 1156, 336, 1155], "text": "perform"}, {"boundingBox": [447, 1127, 478, 1127, 477, 1156, 446, 1156], "text": "an"}, {"boundingBox": [485, 1127, 581, 1128, 581, 1157, 485, 1156], "text": "in-vitro"}, {"boundingBox": [587, 1128, 657, 1128, 657, 1158, 586, 1157], "text": "study"}, {"boundingBox": [663, 1128, 690, 1128, 690, 1158, 663, 1158], "text": "to"}, {"boundingBox": [697, 1128, 804, 1127, 804, 1158, 697, 1158], "text": "evaluate"}, {"boundingBox": [810, 1127, 853, 1127, 853, 1158, 810, 1158], "text": "the"}, {"boundingBox": [859, 1127, 906, 1127, 906, 1158, 859, 1158], "text": "cell"}, {"boundingBox": [912, 1127, 1002, 1127, 1002, 1158, 911, 1158], "text": "growth"}, {"boundingBox": [1010, 1127, 1057, 1126, 1057, 1158, 1009, 1158], "text": "and"}, {"boundingBox": [1062, 1126, 1111, 1126, 1111, 1158, 1062, 1158], "text": "cell"}, {"boundingBox": [1117, 1126, 1208, 1125, 1207, 1158, 1117, 1158], "text": "growth"}, {"boundingBox": [1213, 1125, 1338, 1124, 1338, 1157, 1213, 1158], "text": "inhibition"}]}, {"boundingBox": [302, 1157, 534, 1158, 533, 1186, 301, 1185], "text": "with piogliatzone", "words": [{"boundingBox": [304, 1158, 361, 1158, 362, 1186, 305, 1184], "text": "with"}, {"boundingBox": [366, 1158, 530, 1159, 530, 1185, 367, 1186], "text": "piogliatzone"}]}, {"boundingBox": [259, 1193, 288, 1195, 288, 1216, 259, 1215], "text": "e.", "words": [{"boundingBox": [259, 1192, 286, 1193, 285, 1215, 257, 1214], "text": "e."}]}, {"boundingBox": [291, 1188, 1329, 1188, 1329, 1222, 292, 1223], "text": "to investigate carbonic anhydrase inhibiting activity of NN622, pioglitazone and", "words": [{"boundingBox": [304, 1193, 329, 1193, 329, 1219, 304, 1218], "text": "to"}, {"boundingBox": [336, 1193, 478, 1193, 478, 1221, 336, 1219], "text": "investigate"}, {"boundingBox": [483, 1193, 595, 1193, 594, 1222, 483, 1221], "text": "carbonic"}, {"boundingBox": [600, 1193, 730, 1193, 729, 1223, 599, 1222], "text": "anhydrase"}, {"boundingBox": [735, 1193, 862, 1192, 861, 1224, 734, 1223], "text": "inhibiting"}, {"boundingBox": [869, 1192, 965, 1192, 964, 1224, 868, 1224], "text": "activity"}, {"boundingBox": [972, 1192, 999, 1191, 998, 1224, 971, 1224], "text": "of"}, {"boundingBox": [1004, 1191, 1109, 1191, 1108, 1223, 1003, 1224], "text": "NN622,"}, {"boundingBox": [1114, 1191, 1274, 1189, 1273, 1222, 1113, 1223], "text": "pioglitazone"}, {"boundingBox": [1281, 1189, 1328, 1188, 1327, 1222, 1280, 1222], "text": "and"}]}, {"boundingBox": [296, 1224, 471, 1223, 472, 1251, 297, 1252], "text": "rosiglitazone", "words": [{"boundingBox": [304, 1224, 471, 1225, 471, 1252, 303, 1252], "text": "rosiglitazone"}]}, {"boundingBox": [251, 1253, 1146, 1255, 1145, 1285, 250, 1284], "text": "f. to compare PPAR agonists in terms of alpha and gamma activities", "words": [{"boundingBox": [257, 1256, 284, 1256, 282, 1281, 256, 1281], "text": "f."}, {"boundingBox": [305, 1256, 330, 1256, 328, 1282, 303, 1281], "text": "to"}, {"boundingBox": [338, 1256, 448, 1256, 447, 1283, 336, 1282], "text": "compare"}, {"boundingBox": [455, 1256, 531, 1257, 529, 1284, 453, 1283], "text": "PPAR"}, {"boundingBox": [542, 1257, 649, 1257, 648, 1285, 541, 1284], "text": "agonists"}, {"boundingBox": [654, 1257, 679, 1257, 678, 1285, 653, 1285], "text": "in"}, {"boundingBox": [685, 1257, 759, 1257, 759, 1286, 684, 1285], "text": "terms"}, {"boundingBox": [764, 1257, 794, 1257, 793, 1286, 764, 1286], "text": "of"}, {"boundingBox": [799, 1257, 870, 1256, 869, 1286, 798, 1286], "text": "alpha"}, {"boundingBox": [875, 1256, 922, 1256, 922, 1286, 874, 1286], "text": "and"}, {"boundingBox": [931, 1256, 1025, 1256, 1024, 1285, 930, 1286], "text": "gamma"}, {"boundingBox": [1030, 1256, 1145, 1255, 1144, 1285, 1029, 1285], "text": "activities"}]}, {"boundingBox": [257, 1289, 915, 1291, 914, 1320, 256, 1318], "text": "g. to differentiate between glitazones and glitazars", "words": [{"boundingBox": [257, 1290, 288, 1290, 290, 1318, 258, 1318], "text": "g."}, {"boundingBox": [303, 1290, 331, 1290, 332, 1318, 304, 1318], "text": "to"}, {"boundingBox": [340, 1290, 493, 1290, 494, 1319, 341, 1318], "text": "differentiate"}, {"boundingBox": [498, 1290, 607, 1291, 609, 1319, 500, 1319], "text": "between"}, {"boundingBox": [615, 1291, 746, 1291, 747, 1319, 616, 1319], "text": "glitazones"}, {"boundingBox": [751, 1292, 799, 1292, 801, 1319, 753, 1319], "text": "and"}, {"boundingBox": [805, 1292, 914, 1293, 915, 1318, 806, 1319], "text": "glitazars"}]}, {"boundingBox": [255, 1326, 286, 1324, 287, 1344, 256, 1346], "text": "h.", "words": [{"boundingBox": [255, 1325, 285, 1324, 286, 1343, 257, 1345], "text": "h."}]}, {"boundingBox": [300, 1318, 1100, 1320, 1100, 1353, 299, 1351], "text": "to consult with non-clinical external experts for their expertise", "words": [{"boundingBox": [304, 1321, 331, 1321, 332, 1349, 304, 1349], "text": "to"}, {"boundingBox": [337, 1321, 431, 1322, 432, 1349, 337, 1349], "text": "consult"}, {"boundingBox": [437, 1322, 494, 1322, 494, 1349, 437, 1349], "text": "with"}, {"boundingBox": [499, 1322, 655, 1322, 655, 1349, 500, 1348], "text": "non-clinical"}, {"boundingBox": [660, 1322, 765, 1322, 766, 1349, 661, 1349], "text": "external"}, {"boundingBox": [771, 1322, 865, 1321, 866, 1350, 771, 1349], "text": "experts"}, {"boundingBox": [871, 1321, 910, 1321, 910, 1351, 871, 1350], "text": "for"}, {"boundingBox": [915, 1321, 976, 1321, 976, 1351, 915, 1351], "text": "their"}, {"boundingBox": [982, 1321, 1100, 1320, 1100, 1353, 982, 1351], "text": "expertise"}]}, {"boundingBox": [249, 1353, 956, 1355, 955, 1383, 248, 1381], "text": "i. to find a rationale for not doing clinical monitoring", "words": [{"boundingBox": [255, 1354, 283, 1354, 281, 1381, 253, 1381], "text": "i."}, {"boundingBox": [304, 1354, 331, 1354, 329, 1381, 303, 1381], "text": "to"}, {"boundingBox": [336, 1354, 391, 1354, 389, 1382, 334, 1381], "text": "find"}, {"boundingBox": [396, 1354, 412, 1355, 411, 1382, 395, 1382], "text": "a"}, {"boundingBox": [418, 1355, 533, 1355, 531, 1382, 416, 1382], "text": "rationale"}, {"boundingBox": [538, 1355, 577, 1355, 575, 1382, 536, 1382], "text": "for"}, {"boundingBox": [582, 1355, 630, 1355, 629, 1383, 581, 1382], "text": "not"}, {"boundingBox": [635, 1355, 706, 1355, 705, 1383, 634, 1383], "text": "doing"}, {"boundingBox": [711, 1355, 807, 1355, 806, 1383, 710, 1383], "text": "clinical"}, {"boundingBox": [812, 1355, 956, 1356, 954, 1384, 811, 1383], "text": "monitoring"}]}, {"boundingBox": [252, 1389, 284, 1387, 285, 1413, 253, 1415], "text": "j-", "words": [{"boundingBox": [254, 1388, 282, 1387, 284, 1413, 256, 1414], "text": "j-", "confidence": "Low"}]}, {"boundingBox": [294, 1386, 575, 1385, 576, 1414, 295, 1415], "text": "a monotoring method", "words": [{"boundingBox": [304, 1386, 319, 1386, 318, 1415, 303, 1415], "text": "a"}, {"boundingBox": [325, 1386, 477, 1387, 476, 1416, 324, 1415], "text": "monotoring"}, {"boundingBox": [482, 1387, 576, 1387, 576, 1414, 482, 1415], "text": "method"}]}, {"boundingBox": [251, 1416, 287, 1415, 288, 1444, 252, 1444], "text": "k .", "words": [{"boundingBox": [254, 1414, 266, 1414, 266, 1443, 254, 1443], "text": "k"}, {"boundingBox": [271, 1414, 287, 1414, 287, 1443, 272, 1443], "text": "."}]}, {"boundingBox": [292, 1418, 558, 1417, 559, 1447, 293, 1448], "text": "a case control study", "words": [{"boundingBox": [303, 1420, 320, 1420, 320, 1448, 304, 1448], "text": "a"}, {"boundingBox": [325, 1419, 382, 1418, 383, 1447, 325, 1448], "text": "case"}, {"boundingBox": [388, 1418, 481, 1418, 481, 1447, 388, 1447], "text": "control"}, {"boundingBox": [487, 1418, 558, 1421, 558, 1447, 487, 1447], "text": "study"}]}, {"boundingBox": [253, 1445, 707, 1451, 706, 1484, 252, 1479], "text": "1. a pharmacoepidemiology study", "words": [{"boundingBox": [253, 1447, 282, 1448, 284, 1476, 254, 1475], "text": "1."}, {"boundingBox": [303, 1449, 319, 1450, 321, 1478, 304, 1477], "text": "a"}, {"boundingBox": [325, 1450, 628, 1453, 630, 1482, 326, 1478], "text": "pharmacoepidemiology"}, {"boundingBox": [634, 1453, 704, 1451, 705, 1480, 635, 1482], "text": "study"}]}, {"boundingBox": [253, 1479, 1158, 1481, 1157, 1515, 252, 1513], "text": "m. to submit a report from a Japanese follow up study for pioglitazone", "words": [{"boundingBox": [255, 1483, 298, 1483, 297, 1511, 254, 1511], "text": "m."}, {"boundingBox": [303, 1483, 330, 1483, 330, 1511, 303, 1511], "text": "to"}, {"boundingBox": [337, 1483, 427, 1483, 426, 1511, 337, 1511], "text": "submit"}, {"boundingBox": [432, 1483, 448, 1483, 448, 1511, 432, 1511], "text": "a"}, {"boundingBox": [454, 1483, 533, 1483, 532, 1511, 453, 1511], "text": "report"}, {"boundingBox": [538, 1483, 592, 1483, 591, 1511, 537, 1511], "text": "from"}, {"boundingBox": [608, 1483, 624, 1483, 623, 1511, 607, 1511], "text": "a"}, {"boundingBox": [630, 1483, 744, 1482, 743, 1512, 629, 1511], "text": "Japanese"}, {"boundingBox": [750, 1482, 827, 1482, 826, 1512, 749, 1512], "text": "follow"}, {"boundingBox": [839, 1482, 874, 1482, 872, 1513, 838, 1512], "text": "up"}, {"boundingBox": [881, 1482, 952, 1482, 951, 1513, 879, 1513], "text": "study"}, {"boundingBox": [958, 1482, 996, 1482, 994, 1514, 956, 1513], "text": "for"}, {"boundingBox": [1001, 1482, 1157, 1481, 1155, 1515, 999, 1514], "text": "pioglitazone"}]}, {"boundingBox": [259, 1515, 977, 1517, 977, 1547, 258, 1545], "text": "n. to assess cases from database search for pioglitazone", "words": [{"boundingBox": [260, 1517, 289, 1517, 288, 1545, 259, 1545], "text": "n.", "confidence": "Low"}, {"boundingBox": [303, 1517, 330, 1517, 329, 1545, 302, 1545], "text": "to"}, {"boundingBox": [337, 1517, 416, 1517, 416, 1545, 337, 1545], "text": "assess"}, {"boundingBox": [422, 1517, 492, 1517, 491, 1545, 421, 1545], "text": "cases"}, {"boundingBox": [497, 1517, 553, 1517, 552, 1545, 497, 1545], "text": "from"}, {"boundingBox": [569, 1517, 678, 1517, 678, 1546, 568, 1545], "text": "database"}, {"boundingBox": [684, 1517, 766, 1517, 766, 1546, 684, 1546], "text": "search"}, {"boundingBox": [774, 1517, 811, 1517, 811, 1547, 773, 1546], "text": "for"}, {"boundingBox": [817, 1517, 976, 1517, 977, 1547, 817, 1547], "text": "pioglitazone"}]}, {"boundingBox": [53, 2125, 531, 2126, 530, 2156, 53, 2156], "text": "Confidential - Subject to Protective Order", "words": [{"boundingBox": [56, 2126, 190, 2127, 190, 2157, 56, 2157], "text": "Confidential"}, {"boundingBox": [197, 2127, 213, 2127, 213, 2157, 196, 2157], "text": "-"}, {"boundingBox": [219, 2128, 305, 2128, 305, 2157, 219, 2157], "text": "Subject"}, {"boundingBox": [311, 2128, 333, 2128, 333, 2157, 311, 2157], "text": "to"}, {"boundingBox": [339, 2128, 455, 2127, 456, 2156, 339, 2157], "text": "Protective"}, {"boundingBox": [461, 2127, 529, 2127, 531, 2156, 462, 2156], "text": "Order"}]}, {"boundingBox": [1300, 2125, 1592, 2124, 1593, 2156, 1300, 2157], "text": "TAK-THOMCL-00019749", "words": [{"boundingBox": [1305, 2125, 1594, 2125, 1594, 2157, 1305, 2158], "text": "TAK-THOMCL-00019749"}]}, {"boundingBox": [1299, 2163, 1666, 2161, 1667, 2191, 1300, 2192], "text": "Produced in MDL on 09/14/12", "words": [{"boundingBox": [1301, 2164, 1419, 2164, 1419, 2190, 1300, 2192], "text": "Produced"}, {"boundingBox": [1425, 2164, 1449, 2164, 1449, 2189, 1425, 2190], "text": "in"}, {"boundingBox": [1455, 2164, 1514, 2164, 1514, 2189, 1454, 2189], "text": "MDL"}, {"boundingBox": [1520, 2164, 1551, 2164, 1551, 2189, 1519, 2189], "text": "on"}, {"boundingBox": [1558, 2164, 1666, 2162, 1666, 2191, 1558, 2189], "text": "09/14/12"}]}, {"boundingBox": [384, 2194, 1309, 2193, 1309, 2231, 385, 2232], "text": "Source: https://www.indupbodocoboosts.ucsf.edu/docs/pljf0226", "words": [{"boundingBox": [389, 2197, 503, 2197, 503, 2230, 390, 2229], "text": "Source:"}, {"boundingBox": [509, 2196, 1309, 2193, 1309, 2230, 510, 2231], "text": "https://www.indupbodocoboosts.ucsf.edu/docs/pljf0226", "confidence": "Low"}]}]}]}